Exposure to high levels of indoor allergens (e.g., from cockroaches and rodents) is thought to be one factor among the multiple causes of the disproportionate burden of asthma in disadvantaged urban neighborhoods of New York City. This study is testing an intervention to reduce exposure to indoor allergens among asthmatic children in NYC, and examining the correlation of such reductions with inprovements in allergic sensitization and/or asthma symptoms. We are recruiting 70 asthmatic children who are allergic to cockroaches and live in apartments with reported cockroach infestation. Each apartment undergoes a baseline inspection and environmental assessment, including dust sample collection of indoor allergens. Individual sensitization to allergens is assessed in the asthmatic children via skin prick test and serum IgE. Asthma symptoms are assessed using standardized questionnaires. All homes will undergo a comprehensive pest control intervention; however, half of the homes will undergo intervention at the beginning of the study, and the other half will undergo intervention after eight months. Selection for these two groups will be done randomly. The intervention consists of the following: sealing all cracks and crevices in the structural envelope of the apartment, application of low toxicity pesticides, thorough cleaning of surfaces, elimination of food and water sources, and education regarding the maintenance of a pest-free environment. As part of sub-study in 20 homes, we are collecting indooor air samples from the bedroom and kitchen before and after the intervention. Follow-up assesment of allergen exposures, immunologic sensitization, and asthma symptoms will be made at 4 and 8 months following baseline in the group that undergoes intervention at the beginning of the study; and at 4,7,12 and 16 months following baseline in the group that undergoes intervention after 8 months.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
Budget End
Support Year
29
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Melhem, Nadine M; Keilp, John G; Porta, Giovanna et al. (2016) Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior. Neuropsychopharmacology 41:1447-56
Dong, Chuanhui; Della-Morte, David; Rundek, Tatjana et al. (2016) Evidence to Maintain the Systolic Blood Pressure Treatment Threshold at 140 mm?Hg for Stroke Prevention: The Northern Manhattan Study. Hypertension 67:520-6
Buckley, Jessie P; Engel, Stephanie M; Braun, Joseph M et al. (2016) Prenatal Phthalate Exposures and Body Mass Index Among 4- to 7-Year-old Children: A Pooled Analysis. Epidemiology 27:449-58
Leung, Vivien; Chiu, Ya-Lin; Kotler, Donald P et al. (2016) Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation. HIV Clin Trials 17:55-62
Rosenbaum, Michael; Leibel, Rudolph L (2016) Models of energy homeostasis in response to maintenance of reduced body weight. Obesity (Silver Spring) 24:1620-9
Garyu, Justin W; Meffre, Eric; Cotsapas, Chris et al. (2016) Progress and challenges for treating Type 1 diabetes. J Autoimmun 71:1-9
Widen, Elizabeth M; Whyatt, Robin M; Hoepner, Lori A et al. (2016) Gestational weight gain and obesity, adiposity and body size in African-American and Dominican children in the Bronx and Northern Manhattan. Matern Child Nutr 12:918-28
Maresca, Michelle M; Hoepner, Lori A; Hassoun, Abeer et al. (2016) Prenatal Exposure to Phthalates and Childhood Body Size in an Urban Cohort. Environ Health Perspect 124:514-20
Tooley, James E; Vudattu, Nalini; Choi, Jinmyung et al. (2016) Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes. Eur J Immunol 46:230-41
Cowell, Whitney J; Lederman, Sally A; Sjödin, Andreas et al. (2015) Prenatal exposure to polybrominated diphenyl ethers and child attention problems at 3-7 years. Neurotoxicol Teratol 52:143-50

Showing the most recent 10 out of 1103 publications